scholarly journals Spectroscopic Measurement of Methylene Blue Distribution in Organs and Tissues of Hamadryas Baboons during Oral Administration

Photonics ◽  
2021 ◽  
Vol 8 (8) ◽  
pp. 294
Author(s):  
Elizaveta I. Kozlikina ◽  
Daria V. Pominova ◽  
Anastasia V. Ryabova ◽  
Kanamat T. Efendiev ◽  
Aleksei S. Skobeltsin ◽  
...  
Keyword(s):  
Methylene Blue ◽  
Oral Administration ◽  
Antiviral Drug ◽  
Spectroscopic Measurement ◽  
Cellular Damage ◽  
Autoimmune Response ◽  
Hamadryas Baboon ◽  
Cytokine Storm ◽  
Hamadryas Baboons ◽  
New Research

New research on Methylene Blue (MB), carried out in 2020, shows that it can be an effective antiviral drug as part of COVID-19 treatment. According to the research findings, MB has potential as a direct antiviral drug for the prevention and treatment of COVID-19 in the first stages of the disease. However, the MB accumulation by various types of tissues, as well as by immune cells, has not been previously studied. Therefore, the objective of this study was to obtain spectral data on the interstitial distribution of the administered drug in endothelial tissues in primates. The data on interstitial MB distribution obtained by spectroscopic measurement at both macro- and microlevels during oral administration to Hamadryas baboon individuals demonstrate that MB accumulates in mucous membranes of gastrointestinal tract and the tissues of the respiratory, cardiovascular, immune, and nervous systems. Additionally, it was found that MB was present in lung and brain myeloid cells in significant concentrations, which makes it potentially useful for protection from autoimmune response (cytokine storm) and as a tool for the correction of immunocompetent cells’ functional state during laser irradiation. Since the cytokine storm starts from monocytic cells during SARS-CoV-2 cellular damage and since tumor-associated macrophages can significantly alter tumor metabolism, accumulation of MB in these cells provides a reason to conclude that the immune response correction in COVID-19 patients and change in macrophages phenotype can be achieved by deactivation of inflammatory macrophages in tissues with MB using laser radiation of red spectral range.

Eyeworm infections ofOxyspirura petrowi, Skrjabin, 1929 (Spirurida: Thelaziidae), in species of quail from Texas, New Mexico and Arizona, USA

2016 ◽  
Vol 91 (4) ◽  
pp. 491-496 ◽  
Author(s):  
N.R. Dunham ◽  
R.J. Kendall
Keyword(s):  
New Mexico ◽  
Population Decline ◽  
Northern Bobwhite ◽  
Cellular Damage ◽  
Scaled Quail ◽  
Callipepla Squamata ◽  
The Past ◽  
New Research ◽  
Gambel's Quail ◽  
Historical Range

AbstractNorthern bobwhite (Colinus virginianus) and Scaled quail (Callipepla squamata) have been declining steadily throughout much of their historical range over the past few decades. Even the Rolling Plains of Texas, historically rich with wild quail and one of the last remaining quail strongholds, has been suffering a population decline, most notably since 2010. Gambel's quail (Callipepla gambelii) have also been experiencing their own decline throughout their respective range, but not as significant as that of other species of quail. Eyeworms (Oxyspirura petrowi) in quail have been recognized for years but not thoroughly studied until recently. New research reveals thatO. petrowiinfection can cause inflammation, oedema, and cellular damage to the eye of the quail host. The objective of this research was to better understand the prevalence of the eyeworm infection in different quail species, expand on known distribution, and determine if there is a relationship between location and species infected with eyeworms. Northern bobwhite, Scaled quail and Gambel's quail were hunter-donated from one county within Texas, New Mexico and Arizona, and examined for the prevalence, mean abundance and mean intensity of eyeworm infection from November 2013 to February 2014. Quail from every location were found to have individuals with a varying degree of eyeworm infection. This is the first study to document eyeworm infection in Gambel's quail and in quail in New Mexico and Arizona, and reports the highest eyeworm infection found in Northern bobwhite and Scaled quail.

scholarly journals Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice

2021 ◽  
Vol 11 ◽  
Author(s):  
Hailong Li ◽  
Rui Liu ◽  
Ruotong Zhang ◽  
Shanshan Zhang ◽  
Yiying Wei ◽  
...  
Keyword(s):  
Pulmonary Fibrosis ◽  
Mouse Model ◽  
Antiviral Drug ◽  
Dynamic Compliance ◽  
Serum Levels ◽  
Inflammatory Factors ◽  
Cytokine Storm ◽  
Viral Immunology ◽  
Sepsis Induction ◽  
Sepsis Score

From the perspective of epidemiology, viral immunology and current clinical research, pulmonary fibrosis may become one of the complications of patients with Coronavirus Disease 2019 (COVID-19). Cytokine storm is a major cause of new coronavirus death. The purpose of this study was to explore the effects of antiviral drug arbidol on cytokine storm and pulmonary fibrosis. Here, we use a mouse model of bleomycin-induced pulmonary fibrosis and a mouse model of fecal dilution-induced sepsis to evaluate the effects of arbidol on pulmonary fibrosis and cytokine storm. The results showed that arbidol significantly reduced the area of pulmonary fibrosis and improved lung function (reduced inspiratory resistance, lung dynamic compliance and forced vital capacity increased). Treatment with arbidol promoted reduced sepsis severity 48 h after sepsis induction, based on weight, murine sepsis score and survival rate. Arbidol observably alleviates inflammatory infiltrates and injury in the lungs and liver. Finally, we also found that arbidol reduced serum levels of pro-inflammatory factors such as TNF-α and IL-6 induced by fecal dilution. In conclusion, our results indicate that arbidol can alleviate the severity of pulmonary fibrosis and sepsis, and provide some reference for the treatment of cytokine storm and sequelae of pulmonary fibrosis in patients with COVID-19.

scholarly journals Evaluation of mutagenicity, genotoxicity and chronic toxicity of antiviral drug imidazolyl ethanamide pentandioic acid in in vitro and in vivo test systems

2021 ◽  
Vol 98 (5) ◽  
pp. 548-557
Author(s):  
E. A. Jain ◽  
D. Pleimes ◽  
A. A. Globenko
Keyword(s):  
Oral Administration ◽  
Chromosomal Aberrations ◽  
Ames Test ◽  
Chronic Toxicity ◽  
Micronucleus Test ◽  
Human Lymphocytes ◽  
Antiviral Drug ◽  
Systemic Exposure

Introduction. The antiviral properties of imidazolyl ethanamide pentandioic acid (IPA), the active compound of the drug product, has been proven in various experimental models. However, the literature data on the toxicological properties of IPA are limited.Purpose. To evaluate mutagenic and genotoxic properties in in vitro and in vivo models, as well as to study the toxicity of IPA following chronic oral administration to rats and dogs.Materials and methods. Mutagenic and genotoxic properties of IPA were assessed using the Ames test, the test of chromosomal aberrations in human lymphocytes, and the micronucleus test in rats. The chronic toxicity of IPA was studied in Sprague Dawley rats and beagle dogs of both sexes, to which IPA was administered orally at doses of 30-300 mg/kg/day for 26 and 39 weeks, respectively.Results and discussion. In the Ames test, the addition of IPA up to the maximum dose (5000 mcg/plate) did not result in the increase in the number of revertant colonies. At a concentration of up to 5000 mcg/ml, IPA did not cause chromosomal aberrations in human leukocytes. At doses doses ≤ 2000 mg/kg, IPA did not increase the amount of micronuclei in the bone marrow of rats. In chronic experiments, animals tolerated the administration of IPA well: the dose without an observed effect (NOEL) for rats and dogs was 300 mg/kg/day.Conclusion. IPA did not show mutagenic and genotoxic properties in standard in vitro and in vivo tests. With chronic oral administration to rats and dogs, NOEL IPA equal to 300 mg/kg/day provided a systemic exposure that was 8-10 and 41-65 times higher than that in humans, respectively. The results obtained allow us to consider the safety profile of the prolonged use in humans as favorable.

scholarly journals The Emerging Relevance of AIM2 in Liver Disease

2020 ◽  
Vol 21 (18) ◽  
pp. 6535
Author(s):  
Beatriz Lozano-Ruiz ◽  
José M. González-Navajas
Keyword(s):  
Liver Disease ◽  
Inflammatory Diseases ◽  
Research Area ◽  
Cellular Damage ◽  
Inflammasome Activation ◽  
Immune Recognition ◽  
Alcoholic Fatty Liver ◽  
Hepatic Diseases ◽  
Life Threatening ◽  
New Research

Absent in melanoma 2 (AIM2) is a cytosolic receptor that recognizes double-stranded DNA (dsDNA) and triggers the activation of the inflammasome cascade. Activation of the inflammasome results in the maturation of inflammatory cytokines, such as interleukin (IL)-1 β and IL-18, and a form of cell death known as pyroptosis. Owing to the conserved nature of its ligand, AIM2 is important during immune recognition of multiple pathogens. Additionally, AIM2 is also capable of recognizing host DNA during cellular damage or stress, thereby contributing to sterile inflammatory diseases. Inflammation, either in response to pathogens or due to sterile cellular damage, is at the center of the most prevalent and life-threatening liver diseases. Therefore, during the last 15 years, the study of inflammasome activation in the liver has emerged as a new research area in hepatology. Here, we discuss the known functions of AIM2 in the pathogenesis of different hepatic diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), hepatitis B, liver fibrosis, and hepatocellular carcinoma (HCC).

Oral Administration of Methylene Blue to Patients with Renal Calculi

1967 ◽  
Vol 97 (5) ◽  
pp. 783-789 ◽  
Author(s):  
W.H. Boyce ◽  
W.M. Mckinney ◽  
Thomas T. Long ◽  
George W. Drach
Keyword(s):  
Methylene Blue ◽  
Oral Administration ◽  
Renal Calculi

scholarly journals Serological evidence of coronavirus infections in native hamadryas baboons (Papio hamadryas hamadryas) of the Kingdom of Saudi Arabia

2017 ◽  
Vol 145 (10) ◽  
pp. 2030-2037 ◽  
Author(s):  
A.O. OLARINMOYE ◽  
B.O. OLUGASA ◽  
H. NIPHUIS ◽  
R.V. HERWIJNEN ◽  
E. VERSCHOOR ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Viral Infections ◽  
Papio Hamadryas ◽  
Enzyme Linked Immunosorbent Assay ◽  
Hamadryas Baboon ◽  
Indigenous Species ◽  
Kingdom Of Saudi Arabia ◽  
Hamadryas Baboons ◽  
Papio Hamadryas Hamadryas ◽  
Coronavirus Infections

SUMMARYThe hamadryas baboon (Papio hamadryas hamadryas) is the only indigenous species of non-human primates (NHP) found in the Kingdom of Saudi Arabia (KSA). There are no peer-reviewed publications on viral infections of the baboons of KSA. Apart from camels, other animals are likely sources of the novel Middle East Respiratory Syndrome coronavirus (MERSCoV) for humans. We investigated evidence of highly pathogenic coronavirus infections including MERSCoV in a large group of commensal baboons accompanied by feral dogs, on the outskirts of Ta'if city, KSA, in February 2013. Fifty baboons (16 juveniles and 34 adults) were screened for serum antibodies to human coronaviruses (HCoV-043/-NL63/-229) and canine coronaviruses (CCoV-1-3) using direct Enzyme-linked Immunosorbent Assay (ELISA) technique and for MERSCoV antibodies using Serum Neutralization Test (SNT). Of the 50 sampled baboons, 22% (n= 11) were seropositive to HCoVs, 10% (n= 5) were seropositive to CCoVs, while none had detectable MERSCoV antibodies. These findings bear potentially significant implications for public health, canine health and baboon conservation efforts, necessitating follow-up investigations and preventive measures at locations where baboons frequent human habitations, or are regarded as tourist attractions, in KSA.

scholarly journals Investigation of the Behavioural Response of a Colony of Group-Housed  Hamadryas Baboons (Papio Cynocephalus Hamadryas) to Relocation to a More Naturalistic Enclosure

2021 ◽  
Author(s):  
◽  
Ruth Laura Wood
Keyword(s):  
Environmental Enrichment ◽  
Primary Objective ◽  
Specific Information ◽  
Hamadryas Baboon ◽  
Papio Cynocephalus ◽  
Current Management ◽  
Hamadryas Baboons ◽  
Management Philosophy ◽  
Natural Leaf ◽  
Species Specific

<p>As part of Wellington Zoo’s current management philosophy to reduce the number of species and increase enclosure size, quality and appropriateness for those remaining animals, the zoo’s colony of hamadryas baboons (Papio cynocephalus hamadryas) was relocated within the zoo to a purpose-designed and more naturalistic exhibit. The primary objective of this investigation was to determine group and individual responses of five of these baboons to their new enclosure. In so doing, this investigation was intended to address the shortage of quantitative, species-specific information on environmental enrichment for Papio baboons (Kessel and Brent 1996). The data collection method used in this investigation consisted of fifteen-minute focal sampling of each of the five focal animals in the two months before and the month following the colony’s relocation. For the purposes of this investigation, these focal samples were initially analysed together, prior to each focal animal being considered independently. Analysis of data extracted from these focal samples included consideration of: • The overall occurrence of individual behaviours between the former and new enclosures; • Additions to the animals’ behavioural repertoires upon relocation; and, • Time the animals spent alone and interacting socially. Upon the colony’s relocation, changes in the combined focal animals’ behaviour were anticipated as a result of greater space, areas of privacy, and increased environmental variation. Focal sampling revealed increasingly naturalistic behaviours, including a reduction in vacuum and vestigial behaviours, and an increase in speciestypical behaviour. Results also indicated that the combined focal animals experienced unexpectedly low levels of “agonistic” (i.e. aggressive) behaviour in both enclosures. However, there was a reduction in some associated behaviours upon the colony’s relocation. This included a decline in male rivalry over females. Differences in the responses of individual focal animals to relocation were also anticipated. Of particular interest were results indicating an increasing similarity of individual roles within one-male units to those of free-ranging hamadryas baboons. These roles were associated with both age and sex. This study raises implications for improving the current management of the Wellington Zoo colony and other captive hamadryas baboon colonies. These include emphasising the importance of appropriate husbandry and feeding schedules. It also raises implications for the future management of other captive Papio baboon colonies in terms of enclosure redesign. These include the benefit of incorporating naturally occurring environmental factors, such as natural leaf litter. This study is also of value from a management perspective as a baseline for future investigations. Such investigations could include long-term monitoring of this colony’s use of environmental enrichment in the new enclosure and consideration of the animals’ behaviour as the colony is encouraged to expand.</p>

scholarly journals The LIFE CYCLE OF COVID-19 STAGES AND TREATMENT

2020 ◽  
Vol 9 (3) ◽  
Author(s):  
Ripu Daman M. Singh ◽  
Nida Malim ◽  
Aves Raza Khan ◽  
Huda Khan ◽  
Nauman Khatib ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Life Cycle ◽  
Severe Acute Respiratory Syndrome ◽  
Late Phase ◽  
Antiviral Drug ◽  
Cytokine Storm ◽  
Clinical Recovery ◽  
The World ◽  
Autoimmune Conditions ◽  
Viral Outbreak

The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)bat viruses, therefore bats could be the possible primary reservoir , which emerged in Wuhan, China and spread around the world. The intermediate source of origin and transfer to humans is not known, however, the rapid human to human transfer has been confirmed widely. There is no clinically approved antiviral drug or vaccine available to be used against COVID-19. However, few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, resulted in clinical recovery. We also discuss the approaches for  therapeutic combinations to cope with this viral outbreak. Chloroquine has been sporadically used in treating SARS-CoV-2 infection. Hydroxychloroquine shares the same mechanism of action as chloroquine, but its more tolerable safety profile makes it the preferred drug to treat malaria and autoimmune conditions. We propose that the immunomodulatory effect of hydroxychloroquine also may be useful in controlling the cytokine storm that occurs late-phase in critically ill SARS-CoV-2 infected patients.

scholarly journals Are herbal drugs effective in COVID management? A review to demystify the current facts and claims

2020 ◽  
Author(s):  
Mohd Riyaz Beg ◽  
Barira Siddiqui ◽  
Pramod Waghmare ◽  
Shital Ghodinde ◽  
Snehal Bikkad
Keyword(s):  
Artemisia Annua ◽  
Scientific Evidence ◽  
Antiviral Drug ◽  
Herbal Medicines ◽  
Structural Diversity ◽  
Viral Disease ◽  
Fast Pace ◽  
New Research

Amid the SARS‐CoV‐2 pandemic, herbal medicines have received much attention in its evidence-based therapeutics. Scientists across the globe are integrating new research at an unprecedented fast pace for the discovery of novel molecules against this deadly viral disease. Ever since ancient times, phytochemicals have long been used traditionally for the cure of many viral diseases and lately many are being tested for their potential against the viral replications/transcriptions. The unmatched structural diversity of phytoconstituents may prove to be a gold mine for antiviral drug discovery. Many plants like Heteromorpha spp ., Bupleurum spp , Scrophularia scorodonia , Artemisia annua , Pyrrosia lingua , Lycoris radiate , and Lindera agregata have also been reported to have antiviral potential against SARS-CoV. Recently many synthetic molecules like remdesivir, tocilizumab, favipirapir, dexamethasone, glucocorticoid, and hydroxychloroquine etc. have been extensively investigated for their potential against the SARS‐CoV‐2, likewise, various plant-based molecules such as scutellarein, silvestrol, tryptanthrin, saikosaponin B2, quercetin, myricetin, caffeic acid, psoralidin, isobavachalcone, and lectins-griffiths in were also found to be equally effective. Needless to mention that, the herbal medicines are a valuable and powerful source of chemical compounds which need further chemical modifications and appropriate in-vitro and in-vivo testings for establishing their safety and efficacy as potential drugs against the battle with coronavirus pandemic. In this review, we will try to highlight the potential phytochemicals candidates with their possible molecular targets against the SARS‐CoV‐2and demystify the myths behind the purported remedies such as herbal therapies, teas, essential oils, tinctures, and silver products such as colloidal silver that have no scientific evidence to prevent or cure COVID-19. Apart from that, this review will also de-fabricate the surgency of objectionable claims that are continuously reckoning towards the treatment of COVID-19 with hundred per cent surety and are propagated by several herbal firms.

Sign in / Sign up

Export Citation Format

Share Document